Sepsis Diagnostics by Microbiology Technology Market Size to Grow At 7.8% CAGR From 2024 to 2030

Sepsis Diagnostics by Microbiology Technology Market Size (2024 - 2030)

As per our research Report, the Sepsis Diagnostics by Microbiology Technology Market is forecasted to be growing at CAGR of 7.8% from 2024 to 2030.

Sepsis (septicemia in British English), or blood infection, is a severe medical condition and can be caused by the body's reaction to an infection harming its tissue and organs. It is symptomized by fever, elevated rates of breathing and heartbeat, and mental confusion. Certain infections such as pneumonia may also result in cough and kidney infections may be linked to painful urination. Infants, the elderly, and others affected by weakened immunity may not show any unique infection symptoms, such as a fever, but instead present a normal body temperature. When severe condition, sepsis can cause impaired organ function or blood flow. Signs include lower blood pressure, increased blood lactate, and low urine output, suggestive of impaired circulation. Septic shock is a condition characterized by low blood pressure due to sepsis that does not better despite fluid replacement.

Sepsis is a critical, life-threatening health condition that can be hard to diagnose owing to the absence of specific symptoms or signs. When doctors are suspicious of sepsis, they observe for more than two infections or related indications, conducting A to Z physical examination, various laboratory tests, and closely observing the condition of the patient. Sepsis can be caused by myriad diseases like pneumonia, diverticulitis, and other infectious organisms, such as bacteria, viruses, or fungi. If the patient shows a combination of symptoms and infections that fall into a risk group, and their medical history represents an impaired immune system, sepsis is suspected. Major fever, hypotension, and loss of consciousness details must be considered and noted, as well as the patient's alcohol use and any current medications. For a sepsis diagnosis, numerous tests are performed to determine the potential and intensity of the sickness, such as a urine test, a blood test, and relevant tests for other medical issues. An in-depth physical examination is also carried out to detect abscesses, prostatitis, or other neutropenic or pelvic infections.

Sepsis is a perilous, life-threatening health condition that occurs when the body responds detrimentally to an infection. It can damage organs and tissues and result in septic shock or death, if not treated quickly. Recent studies advice that around 49 million people suffer from sepsis annually, causing 11 million deaths. Sepsis often comes up from preventable infections in the community and can also be an impact from infections acquired in healthcare settings, which are frequent adverse events affecting millions of patients worldwide every year. Therefore, this factor propels the demand for sepsis diagnostics by microbiology technology.

Various government and non-government organizations are operating vigorously to raise awareness about sepsis. Screening, educational campaigns, enhanced diagnostics, and treatment protocols are being deployed to cut down the deaths associated with sepsis. Global Sepsis Alliance and WHO have collaborated with organizations from across the world to proliferate knowledge about this disease. WHO has enforced the Global Maternal Sepsis Study and Campaign to evaluate and control sepsis cases pertaining to maternal health. Therefore, this factor also pushes the demand for sepsis diagnostics by microbiology technology.

The development of rapid sepsis diagnostic techniques offers a lucrative opportunity in the global sepsis diagnostics by the microbiology technology market. Given the enhancing demand for sepsis diagnostics by microbiology technology due to the rising incidence of sepsis and the growing initiatives by national governments and non-governmental entities toward the treatment of sepsis, businesses expertizing in sepsis diagnostics can stand to gain significantly from this opportunity by developing rapid sepsis diagnosis to reduce delays in antibiotic therapy for sepsis patients. This development will help companies to enhance their customer base and boost their overall revenue.

Key Market Insights: 

  • In 2023, the assays and reagents segment held the biggest market share. The growth can be dedicated to the assays and reagents being essential components of sepsis diagnosis. Procalcitonin and C-reactive protein are two instances of specific blood biomarkers associated with sepsis that can be detected using assays and reagents. These biomarkers are released by the body in response to infection and can be utilized to help in the diagnosis and monitoring of the severity of sepsis. Because they are easy to use, highly sensitive, and specific, assays and reagents have become major parts of sepsis diagnosis and treatment.

  • In 2023, the automated diagnostics segment held the largest market share. The growth can be dedicated to the advantages that automated diagnostics offer in contrast to conventional diagnostics, including better traceability, high efficiency, and removal of repetitive diagnostic practices. The demand for timely sepsis treatment has seen a growth in recent times, leading various significant players in the market to explore strategic initiatives such as mergers and acquisitions, partnerships, and the widening of existing product portfolios to gain a larger share of the market. These strategic moves are pushing the growth of the market. 

  • In 2023, the bacterial sepsis segment held the largest market share. The growth can be dedicated to bacterial sepsis having a higher rate of incidence than other types of pathogens, particularly in healthcare settings, where individuals are more attractive to contract infections. With a heightened risk of contracting sepsis, affected by a wide range of bacteria, such as Staphylococcus aureus, Escherichia coli, and Streptococcus pneumoniae, rapid and timely intervention is required for optimal patient care. 

  • The region of North America led the global sepsis diagnostics by microbiology technology market in the year 2023. The presence of well-established healthcare infrastructure in countries, such as the United States and Canada, the high adoption rate of sepsis diagnostic equipment in laboratory and medical clinics, favourable healthcare reimbursement policies, and the CDC's effort to raise consciousness and prevention of sepsis through the "Get Ahead of Sepsis" campaign are some of the factors pushing the region's growth. The region of Asia-Pacific is expected to expand at the quickest rate over the forecast period due to the rising incidence of sepsis condition, the increasing government's target on the development of healthcare infrastructure in nations, such as China, India, and Japan, and the enhancing awareness about sepsis diagnosis and treatment.

Sepsis Diagnostics by Microbiology Technology Market Segmentation:

By Product

  • Assays & Reagents

  • Blood Culture Media

  • Instruments

  • Software

By Method

  • Automated Diagnostics

  • Conventional Diagnostics

By Pathogen Type

  • Bacterial Sepsis

  • Fungal Sepsis

  • Viral Sepsis

  • Others

By End User

  • Hospitals & Clinics

  • Diagnostic Centers

  • Others

By Region

  • North America

  • Europe

  • Asia-Pacific

  • South America

  • Middle East & Africa

Request sample for this report:






Analyst Support

Every order comes with Analyst Support.


We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.